• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺导管内癌:39名泌尿外科病理学家的观察者间再现性调查

Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.

作者信息

Iczkowski Kenneth A, Egevad Lars, Ma Jun, Harding-Jackson Nicholas, Algaba Ferran, Billis Athanase, Camparo Philippe, Cheng Liang, Clouston David, Comperat Eva M, Datta Milton W, Evans Andrew G, Griffiths David F, Guo Charles C, Hailemariam Seife, Huang Wei, Humphrey Peter A, Jiang Zhong, Kahane Hillel, Kristiansen Glen, La Rosa Francisco G, Lopez-Beltran Antonio, MacLennan Gregory T, Magi-Galluzzi Cristina, Merrimen Jennifer, Montironi Rodolfo, Osunkoya Adeboye O, Picken Maria M, Rao Nagarjun, Shah Rajal B, Shanks Jonathan H, Shen Steven S, Tawfik Ossama W, True Lawrence D, Van der Kwast Theodorus, Varma Murali, Wheeler Thomas M, Zynger Debra L, Sahr Natasha, Bostwick David G

机构信息

Medical College of Wisconsin, Milwaukee, WI.

Karolinska Institutet, Stockholm, Sweden.

出版信息

Ann Diagn Pathol. 2014 Dec;18(6):333-42. doi: 10.1016/j.anndiagpath.2014.08.010. Epub 2014 Sep 3.

DOI:
10.1016/j.anndiagpath.2014.08.010
PMID:25263387
Abstract

The diagnosis of intraductal carcinoma (IDC) of the prostate remains subjective because 3 sets of diagnostic criteria are in use. An internet survey was compiled from 38 photomicrographs showing duct proliferations: 14 signed out as high-grade prostatic intraepithelial neoplasia (HGPIN), 17 IDC, and 7 invasive cribriform/ductal carcinoma. Each image was assessed for the presence of 9 histologic criteria ascribed to IDC. Thirty-nine respondents were asked to rate images as (1) benign/reactive, (2) HGPIN, (3) borderline between HGPIN and IDC, (4) IDC, or (5) invasive cribriform/ductal carcinoma. Intraclass correlation coefficient was 0.68. There was 70% overall agreement with HGPIN, 43% with IDC, and 73% with invasive carcinoma (P < .001, χ(2)). Respondents considered 19 (50%) of 38 cases as IDC candidates, of which 5 (26%) had a two-thirds consensus for IDC; two-thirds consensus for either borderline or IDC was reached in 9 (47%). Two-thirds consensus other than IDC was reached in the remaining 19 of 38 cases, with 15 supporting HGPIN and 4 supporting invasive carcinoma. Findings that differed across diagnostic categories were lumen-spanning neoplastic cells (P < .001), 2× benign duct diameters (P < .001), duct space contours (round, irregular, and branched) (P < .001), papillary growth (P = .048), dense cribriform or solid growth (both P = .023), and comedonecrosis (P = .015). When the 19 of 38 images that attained consensus for HGPIN or invasive carcinoma were removed from consideration, lack of IDC consensus was most often attributable to only loose cribriform growth (5/19), central nuclear maturation (5/19), or comedonecrosis (3/19). Of the 9 histologic criteria, only 1 retained significant correlation with a consensus diagnosis of IDC: the presence of solid areas (P = .038). One case that attained IDC consensus had less than 2× duct enlargement yet still had severe nuclear atypia and nucleomegaly. Six fold nuclear enlargement was not significant (P = .083), although no image had both 6× nuclei and papillary or loose cribriform growth: a combination postulated as sufficient criteria for IDC. Finally, 20.5% of respondents agreed that an isolated diagnosis of IDC on needle biopsy warrants definitive therapy, 20.5% disagreed, and 59.0% considered the decision to depend upon clinicopathologic variables. Although IDC diagnosis remains challenging, we propose these criteria: a lumen-spanning proliferation of neoplastic cells in preexisting ducts with a dense cribriform or partial solid growth pattern. Solid growth, in any part of the duct space, emerges as the most reproducible finding to rule in a diagnosis of IDC. Comedonecrosis is a rarer finding, but in most cases, it should rule in IDC. Duct space enlargement to greater than 2× the diameter of the largest, adjacent benign spaces is usually present in IDC, although there may be rare exceptions.

摘要

前列腺导管内癌(IDC)的诊断仍然具有主观性,因为目前使用着3套诊断标准。我们从38张显示导管增生的显微照片编制了一项网络调查:14张诊断为高级别前列腺上皮内瘤变(HGPIN),17张为IDC,7张为浸润性筛状/导管癌。每张图像都根据9项归因于IDC的组织学标准进行评估。39名受访者被要求将图像评为(1)良性/反应性,(2)HGPIN,(3)HGPIN与IDC之间的临界状态,(4)IDC,或(5)浸润性筛状/导管癌。组内相关系数为0.68。对HGPIN的总体一致性为70%,对IDC的为43%,对浸润性癌的为73%(P <.001,χ(2))。受访者将38例中的19例(50%)视为IDC候选病例,其中5例(26%)对IDC有三分之二的共识;9例(47%)对临界状态或IDC达成了三分之二的共识。在38例中的其余19例中,除IDC外达成了三分之二的共识,15例支持HGPIN,4例支持浸润性癌。不同诊断类别之间存在差异的发现包括跨腔隙的肿瘤细胞(P <.001)、良性导管直径的2倍(P <.001)、导管腔轮廓(圆形、不规则形和分支形)(P <.001)、乳头状生长(P =.048)、致密筛状或实性生长(两者P =.023)以及粉刺样坏死(P =.015)。当从考虑中剔除38张图像中对HGPIN或浸润性癌达成共识的19张后,缺乏IDC共识最常归因于仅疏松筛状生长(5/19)、中央核成熟(5/19)或粉刺样坏死(3/19)。在9项组织学标准中,只有1项与IDC的共识诊断保持显著相关性:实性区域的存在(P =.038)。1例达成IDC共识的病例导管扩张小于2倍,但仍有严重的核异型性和核肿大。核增大6倍并不显著(P =.083),尽管没有图像同时具有6倍核以及乳头状或疏松筛状生长:这种组合被假定为IDC的充分标准。最后,20.5%的受访者同意针吸活检孤立诊断为IDC需要确定性治疗,20.5%不同意该观点,59.0%认为该决定取决于临床病理变量。尽管IDC诊断仍然具有挑战性,但我们提出以下标准:在先前存在的导管内肿瘤细胞的跨腔隙增生,具有致密筛状或部分实性生长模式。导管腔内任何部位的实性生长是诊断IDC最具可重复性的发现。粉刺样坏死是较罕见的发现,但在大多数情况下,它应支持IDC诊断。IDC通常存在导管腔扩张至大于最大相邻良性腔隙直径的2倍,尽管可能有罕见例外。

相似文献

1
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.前列腺导管内癌:39名泌尿外科病理学家的观察者间再现性调查
Ann Diagn Pathol. 2014 Dec;18(6):333-42. doi: 10.1016/j.anndiagpath.2014.08.010. Epub 2014 Sep 3.
2
Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.前列腺非典型筛状病变:与前列腺癌的关系及其对前列腺活检诊断的影响。
Am J Surg Pathol. 2010 Apr;34(4):470-7. doi: 10.1097/PAS.0b013e3181cfc44b.
3
ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.ETS 基因异常在前列腺非典型筛状病变中的意义:有助于鉴别前列腺导管内癌和筛状高级别前列腺上皮内瘤。
Am J Surg Pathol. 2010 Apr;34(4):478-85. doi: 10.1097/PAS.0b013e3181d6827b.
4
Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.前列腺导管内增生性病变的临床病理分析:前列腺导管内癌、高级别前列腺上皮内瘤变和非典型筛状病变。
Hum Pathol. 2014 Aug;45(8):1572-81. doi: 10.1016/j.humpath.2014.03.011. Epub 2014 Apr 12.
5
Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraductal carcinoma of the prostate.前列腺非典型筛状病变:临床意义、鉴别诊断及前列腺导管内癌的当前概念。
Adv Anat Pathol. 2012 Jul;19(4):270-8. doi: 10.1097/PAP.0b013e31825c6c0e.
6
Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.前列腺非典型导管筛状增生具有与前列腺导管癌相似的分子和临床病理特征。
Am J Surg Pathol. 2017 Apr;41(4):550-556. doi: 10.1097/PAS.0000000000000794.
7
Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists.前列腺导管内癌的报告规范:欧洲泌尿病理学家专家调查
J Clin Pathol. 2016 Oct;69(10):852-7. doi: 10.1136/jclinpath-2016-203658. Epub 2016 Feb 29.
8
Intraductal carcinoma of the prostate.前列腺导管内癌。
Arch Pathol Lab Med. 2012 Apr;136(4):418-25. doi: 10.5858/arpa.2011-0519-RA.
9
Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.分子证据表明,浸润性腺癌可通过逆行性腺管定植模仿前列腺上皮内瘤变(PIN)和导管内癌。
J Pathol. 2016 Jan;238(1):31-41. doi: 10.1002/path.4628. Epub 2015 Oct 14.
10
Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.前列腺导管内癌的异质性临床病理特征:“前体样”与“普通型”病变的比较
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2518-26. eCollection 2014.

引用本文的文献

1
Clinical Management of Intraductal Carcinoma of the Prostate.前列腺导管内癌的临床管理
Cancers (Basel). 2024 Apr 25;16(9):1650. doi: 10.3390/cancers16091650.
2
Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.前列腺中的筛状病变:着重于鉴别诊断及临床意义
Cancers (Basel). 2022 Jun 21;14(13):3041. doi: 10.3390/cancers14133041.
3
Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate.
前列腺导管内癌中与生化复发相关的形态学标准的鉴定。
Cancers (Basel). 2021 Dec 13;13(24):6243. doi: 10.3390/cancers13246243.
4
PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer.通过机器学习分析前列腺癌中的PTEN和DNA倍体状态
Cancers (Basel). 2021 Aug 26;13(17):4291. doi: 10.3390/cancers13174291.
5
Interchangeability of light and virtual microscopy for histopathological evaluation of prostate cancer.光学显微镜和虚拟显微镜在前列腺癌组织病理学评估中的可互换性。
Sci Rep. 2021 Feb 5;11(1):3257. doi: 10.1038/s41598-021-82911-z.
6
Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.应用拉曼微光谱技术在组织标本上识别前列腺导管内癌:一项多队列验证的诊断准确性病例对照研究。
PLoS Med. 2020 Aug 14;17(8):e1003281. doi: 10.1371/journal.pmed.1003281. eCollection 2020 Aug.
7
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.2019 年国际泌尿病理学会(ISUP)前列腺癌分级共识会议。
Am J Surg Pathol. 2020 Aug;44(8):e87-e99. doi: 10.1097/PAS.0000000000001497.
8
Intraductal carcinoma of the prostate: a critical re-appraisal.前列腺导管内癌:批判性再评价。
Virchows Arch. 2019 May;474(5):525-534. doi: 10.1007/s00428-019-02544-6. Epub 2019 Mar 1.
9
Comedonecrosis Revisited: Strong Association With Intraductal Carcinoma of the Prostate.再次审视前列腺小囊脓肿:与前列腺导管内癌强烈相关。
Am J Surg Pathol. 2018 Aug;42(8):1036-1041. doi: 10.1097/PAS.0000000000001104.
10
Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.不同的DNA甲基化改变与Gleason 4级前列腺肿瘤中的筛状结构和导管内癌相关。
Oncol Lett. 2017 Jul;14(1):390-396. doi: 10.3892/ol.2017.6140. Epub 2017 May 9.